GHK-Cu (50 mg Vial) Dosage Protocol

Dosing & Reconstitution Overview

GHK-Cu is a naturally occurring tripeptide (glycyl-L-histidyl-L-lysine) bound to a copper(II) ion, studied for its role in tissue remodelling and collagen signalling. The figures below are compiled strictly for laboratory and educational reference — they describe how the compound has been handled and dosed in published work and compounding references, not a recommendation for use in humans or animals.

For a 50 mg vial, adding 3.0 mL of bacteriostatic water yields a concentration of 16.67 mg/mL (16,670 mcg/mL). At that concentration, drawing 6 units (0.06 mL) on a U-100 insulin syringe delivers roughly 1 mg of material, and 12 units (0.12 mL) delivers roughly 2 mg, which keeps the arithmetic straightforward across the dosing steps.

Standard (Gradual) Titration Schedule

The gradual schedule reflects a conservative five-day-per-week pattern drawn from compounding-pharmacy references, where the per-injection amount is stepped up over several weeks to ease into the upper end of the range.

Reconstitution Steps

1. Let the sealed lyophilized vial and the bacteriostatic water reach room temperature, then wipe both stoppers with an alcohol swab.
2. Draw 3.0 mL of bacteriostatic water and inject it slowly down the inside wall of the vial to minimise foaming — never directly onto the powder pellet.
3. Swirl or roll gently until fully dissolved. Do not shake; aggressive agitation can shear the peptide and disrupt the copper complex.
4. The solution should be a clear, faintly blue colour characteristic of the copper complex. Label the vial with the concentration (16.67 mg/mL) and the reconstitution date.
5. Refrigerate at 2–8 °C between uses, protected from light, and draw subsequent volumes with a fresh sterile syringe each time.

Alternative (Three-Times-Weekly) Schedule

A second common pattern from compounding references holds the dose flat at the top of the range but injects only three times per week — for example Monday, Wednesday and Friday — rather than escalating across blocks.

Supplies Needed

• GHK-Cu vials (50 mg): roughly 1 vial for an 8-week run, 2 vials for 12 weeks, and 2–3 vials for a 16-week run depending on whether the schedule is 3×/week or 5 days/week.
• Insulin syringes (U-100, 29–31 gauge): about 24 for an 8-week 3×/week run; up to 80 for a 16-week 5-day/week run (one fresh syringe per draw).
• Bacteriostatic water (10 mL): a single 10 mL bottle covers reconstitution across the typical 1–3 vial protocols.
• Alcohol swabs: one to two 100-count boxes comfortably cover an 8–16 week schedule.

Protocol Overview

• Research goal: model copper-peptide effects on collagen synthesis, tissue remodelling and antioxidant/anti-inflammatory gene regulation.
• Schedule: subcutaneous administration 3–5 days per week in the reference patterns.
• Dose band: 1.0–2.0 mg per injection.
• Fill: 50 mg lyophilized, reconstituted to 16.67 mg/mL with 3 mL diluent.
• Storage: −20 °C dry; 2–8 °C once reconstituted, used within 30 days.

Dosing Protocol Notes

• Begin at the lowest 1 mg step on a gradual schedule and hold each level for about four weeks before stepping up.
• Keep administration on a consistent weekly cadence for steady exposure modelling.
• Choose either the 5-day-per-week escalation or the 3×/week flat pattern rather than mixing them within a cycle.
• Cycles commonly run 4–8 weeks, with extensions toward 16 weeks documented in some references.

Storage Instructions

Keep sealed lyophilized vials at −20 °C or below in dry, dark conditions, ideally with desiccant and a tight seal, where stability extends for many months. Once reconstituted, refrigerate at 2–8 °C (35.6–46.4 °F), protect from light, and use within about 30 days. For longer storage, freeze aliquots at −20 °C and avoid repeated freeze-thaw cycles, which degrade the peptide.

Important Handling Notes

• Use a sterile syringe for every draw and never re-enter the vial with a used needle.
• Allow refrigerated solution to warm slightly before drawing to improve measurement accuracy.
• Protect the solution from prolonged light exposure to preserve the copper complex.
• Document each draw — date, volume, remaining material — for reproducibility.

How GHK-Cu Works

GHK-Cu is a tripeptide that complexes with a copper(II) ion to influence a broad set of regenerative and protective pathways. In published work the molecule has been associated with increased collagen and decorin gene expression in dermal fibroblasts, activation of tissue-remodelling signalling, and modulation of matrix metalloproteinases and their inhibitors. It has also been linked to favourable regulation of genes tied to antioxidant defence and anti-inflammatory responses. Preclinical rodent studies report activity at roughly 0.5 mcg/kg, while applied protocols in human-context references use milligram-range dosing.

Reported Benefits & Side Effects

Effects observed in research

• Support of wound-healing and tissue-repair processes through collagen synthesis and remodelling pathways.
• Positive regulatory effects on genes related to antioxidant enzymes, growth factors and anti-inflammatory signalling.
• Activity in nervous-system and cognitive pathways in preclinical models.
• Established role in dermatological tissue remodelling in the copper-peptide literature.

Side effects reported

• Generally well tolerated in the referenced protocols.
• Most common effects are mild injection-site reactions such as temporary redness or itching.
• Site rotation is used to limit local irritation and lipodystrophy.

Injection & Handling Technique (Reference Only)

• Clean the vial stopper and the chosen site with alcohol swabs and let both air-dry completely before drawing or injecting.
• Pinch a fold of skin and insert subcutaneously at a 45–90° angle depending on needle length; aspiration is not required for subcutaneous work.
• Inject slowly and steadily, then withdraw the needle at the same angle as insertion; press gently with cotton rather than rubbing if needed.
• Rotate sites systematically — for example abdomen at least an inch from the navel, outer thighs and upper arms — and dispose of sharps in an approved container.

References

Related Protocols